Submitted by Anonymous (not verified) on 4 September 2026 - 10:26
Human medicines European public assessment report (EPAR): Repatha, evolocumab, Date of authorisation: 17/07/2015, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Repatha, evolocumab, Date of authorisation: 17/07/2015, Revision: 28, Status: Authorised